[1]
Pinthus, J.H. and Duivenvoorden, W.C. 2017. Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?. Canadian Urological Association Journal. 11, 1-2 (Feb. 2017), 39–40. DOI:https://doi.org/10.5489/cuaj.4394.